Collegium Pharmaceutical Stock Technical Analysis
| COLL Stock | USD 34.50 0.35 1.02% |
As of the 22nd of May, Collegium Pharmaceutical shows the Mean Deviation of 1.88, downside deviation of 3.91, and Risk Adjusted Performance of 0.0409. Collegium Pharmaceutical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Collegium Pharmaceutical, which can be compared to its peers. Please confirm Collegium Pharmaceutical downside deviation, jensen alpha, as well as the relationship between the Jensen Alpha and downside variance to decide if Collegium Pharmaceutical is priced correctly, providing market reflects its regular price of 34.5 per share. Given that Collegium Pharmaceutical has jensen alpha of 0.108, we suggest you to validate Collegium Pharmaceutical's prevailing market performance to make sure the company can sustain itself at a future point.
Collegium Pharmaceutical Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Collegium, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CollegiumCollegium |
Collegium Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Collegium Pharmaceutical Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Collegium Pharmaceutical volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Collegium Pharmaceutical Trend Analysis
Use this graph to draw trend lines for Collegium Pharmaceutical. You can use it to identify possible trend reversals for Collegium Pharmaceutical as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Collegium Pharmaceutical price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Collegium Pharmaceutical Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Collegium Pharmaceutical applied against its price change over selected period. The best fit line has a slop of 0.06 , which may suggest that Collegium Pharmaceutical market price will keep on failing further. It has 122 observation points and a regression sum of squares at 146.22, which is the sum of squared deviations for the predicted Collegium Pharmaceutical price change compared to its average price change.About Collegium Pharmaceutical Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Collegium Pharmaceutical on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Collegium Pharmaceutical based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Collegium Pharmaceutical price pattern first instead of the macroeconomic environment surrounding Collegium Pharmaceutical. By analyzing Collegium Pharmaceutical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Collegium Pharmaceutical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Collegium Pharmaceutical specific price patterns or momentum indicators. Please read more on our technical analysis page.
Collegium Pharmaceutical May 22, 2024 Technical Indicators
Most technical analysis of Collegium help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Collegium from various momentum indicators to cycle indicators. When you analyze Collegium charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0409 | |||
| Market Risk Adjusted Performance | 0.2011 | |||
| Mean Deviation | 1.88 | |||
| Semi Deviation | 3.54 | |||
| Downside Deviation | 3.91 | |||
| Coefficient Of Variation | 1748.98 | |||
| Standard Deviation | 3.17 | |||
| Variance | 10.02 | |||
| Information Ratio | 0.0318 | |||
| Jensen Alpha | 0.108 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.0257 | |||
| Treynor Ratio | 0.1911 | |||
| Maximum Drawdown | 27.59 | |||
| Value At Risk | (3.56) | |||
| Potential Upside | 3.45 | |||
| Downside Variance | 15.27 | |||
| Semi Variance | 12.54 | |||
| Expected Short fall | (1.85) | |||
| Skewness | (1.94) | |||
| Kurtosis | 14.02 |
Collegium Pharmaceutical May 22, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Collegium stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 7,101 | ||
| Daily Balance Of Power | 0.49 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 34.50 | ||
| Day Typical Price | 34.50 | ||
| Price Action Indicator | 0.18 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Collegium Stock analysis
When running Collegium Pharmaceutical's price analysis, check to measure Collegium Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Collegium Pharmaceutical is operating at the current time. Most of Collegium Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Collegium Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Collegium Pharmaceutical's price. Additionally, you may evaluate how the addition of Collegium Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Collegium Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.